In this issue of JAMA Dermatology, Cheraghlou et al1 compare the survival of patients with stage I melanoma treated with Mohs micrographic surgery (MMS) and wide local excision (WLE) in the National Cancer Database (NCDB). The treatment of melanoma with MMS has historically been the subject of controversy, with physicians on either side deeply entrenched in their views. The investigators’ finding that patients undergoing MMS have improved survival, although relatively novel, is not surprising.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Maher IA. Improving Survival for Patients With Early-Stage Melanoma. JAMA Dermatol. 2019;155(11):1229–1230. doi:https://doi.org/10.1001/jamadermatol.2019.2622
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: